A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

This article explores how digital maturity in process design and parameter management can drive significant time and cost ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform. This latest release introduces advanced ...

Martin Grandjean, McGeddon, US Air Force/Wikimedia Commons, CC BY-SA The current drug development process operates like an assembly line, relying on a checkbox approach with extensive testing at each ...

As the kit leverages primary human tissue, it also better supports the development of new, human-specific drug modalities, an area for which traditional preclinical tools often lack the relevant ...

Preclinical Imaging Market is Segmented by Type (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems ...

As investment in drug development continues to rise, and as regional markets mature, the overall demand for preclinical imaging systems is set to expand, solidifying the market's role in advancing ...

The Preclinical Imaging Market is poised for substantial growth, driven by the escalating demand for advanced imaging solutions in drug development and translational research. Researchers increasingly ...

Protheragen launches a full spectrum of ophthalmic drug preclinical R&D services to streamline the complex process of developing effective therapies for eye diseases. Protheragen, a reputable research ...